
About this episode
Aptamers are molecules identified from large combinatorial nucleic acid libraries by their high affinity to target molecules. Due to a variety of desired properties, aptamers are attractive alternatives to antibodies in molecular biology and medical applications. Aptamers are identified through an iterative selection–amplification process known as systematic evolution of ligands by exponential enrichment (SELEX). Although SELEX is typically carried out using purified target molecules, whole live cells are also employable as selection targets. This technology, Cell-SELEX, has several advantages. For example, generated aptamers are functional with a native conformation of the target molecule on live cells, and thus, cell surface transmembrane proteins would be targets even went their purifications in native conformations are difficult. In addition, cell-specific aptamers can be obtained without any knowledge about cell surface molecules on the target cells. Here, I review the progress of Cell-SELEX technology and discuss advantages of the technology
DOI: 10.1089/biores.2012.0253265 - 2012
Get every episode summarized
Each time PubReading publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
Hosts & guests
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from PubReading

PubReading [346] - Transparency Is the Key to Quality - A. Fosang & R. Colbran
PubReading

PubReading [343] - The changing career trajectories of new parents in STEM - E....
PubReading

PubReading [341] - Carbon Nanomaterials (CNMs) in Cancer Therapy- A Database of...
PubReading

PubReading [340] - The application of human tissue for drug discovery and develo...
PubReading